Back to News
Market Impact: 0.3
TELA Bio Says FDA Grants 510(k) Clearance For Liora Monofilament Scaffold Product
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationProduct Launches
TELA Bio announced that the FDA granted 510(k) clearance to its Liora Monofilament Scaffold product. The clearance is a positive regulatory milestone; the article provided no launch timing, financial details, or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
TELA0.75
More News
- OKX debuts a platform that turns 50 currencies into digital dollars, betting emerging market investors want stablecoins
- AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
- Lucid Motors’ EV output falls to lowest level in almost two years
- Nvidia-backed Reflection AI unveils its first open model, Beam. Could it be America’s best chance to compete with China?
- Up 57% since June: this AI-picked pharma stock keeps climbing
- Why is NeoGenomics stock sliding today?